BridgeMD
Prevention study for Stroke
Official title Post-Stroke Secondary Prevention With Digital Monitoring
ClinicalTrials.gov ID: NCT06837311
What this study is testing
What is Biological assessment?
Biological assessment is an investigational medicine, given as an once-daily, being studied as a potential treatment for stroke.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Stroke is the second leading cause of death and a major cause of disability worldwide. In 2019, Disability-Adjusted Life-Years (DALYs) related to stroke was estimated to have reached 143 million.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Male or female
- At least 18 years of age and younger than 80 years;
- Recent (≤ 15 days) clinically symptomatic ischemic or hemorrhagic stroke documented through brain imaging (CT or MRI) or a Transient Ischemic Attack...
- Returning to the neurovascular unit for the standard care post-stroke follow-up visits;
- National Institute Health Stroke Scale (NIHSS) \< 15;
You likely can't join if
- Subarachnoid hemorrhage; Dementia syndrome or other central neurologic disorder;
- Severe aphasia (NIHSS item 9 ≥ 2)
- Severe visual impairment interfering with the completion of evaluations;
- Severely impaired physical and/or mental health that, according to the neurologist, may affect the participant's capacity to participate in the study;
- Individuals already undergoing treatment for tobacco cessation and/or SRADs at admission in the stroke unit;
- Pregnancy or breastfeeding;
See the full eligibility criteria
- Male or female
- At least 18 years of age and younger than 80 years;
- Recent (≤ 15 days) clinically symptomatic ischemic or hemorrhagic stroke documented through brain imaging (CT or MRI) or a Transient Ischemic Attack with an Predictive Risk Score (ABCD2) ≥ 4;
- Returning to the neurovascular unit for the standard care post-stroke follow-up visits;
- National Institute Health Stroke Scale (NIHSS) \< 15;
- modified Rankin scale ≤ 4;
- No severe cognitive impairment as defined by the neurologist;
- Current smokers (smoking at least 1 cigarette per day during the month before admission)
- Able to use a smartphone
- Living in an area with internet coverage
- Written informed consent by the patient;
- Coverage by the French National Health Insurance
- Subarachnoid hemorrhage; Dementia syndrome or other central neurologic disorder;
- Severe aphasia (NIHSS item 9 ≥ 2)
- Severe visual impairment interfering with the completion of evaluations;
- Severely impaired physical and/or mental health that, according to the neurologist, may affect the participant's capacity to participate in the study;
- Individuals already undergoing treatment for tobacco cessation and/or SRADs at admission in the stroke unit;
- Pregnancy or breastfeeding;
- Inability to read French;
- Individuals under legal protection or unable to express personally their consent
- Participation in another protocol modifying the patient's follow-up status.
- Person deprived of liberty
- Person in emergency situation
The study team makes the final eligibility decision.
Where it's taking place
- Bordeaux, France
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bordeaux, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.